Skip to content
🧬 New: 3 PDRN clinical studies added this weekπŸ”¬ 120+ PDRN products compared β€” find your matchπŸ“© Free weekly PDRN research digest β€” subscribe below
PDRN Care

PDRN for Keloid Scars: What the Science Says About Repair and Prevention

Dr. Min-Ji Park

MD, Board-Certified Dermatologist

June 10, 202610 min

What Makes Keloids Different

Most scars are the skin's tidy answer to a wound: fibroblasts lay down collagen, the wound closes, and the cells quiet down. Keloids are what happens when that off-switch fails. A keloid is a scar that keeps growing beyond the boundaries of the original injury, producing a raised, firm, often itchy or tender overgrowth of dense collagen that can extend well outside the original wound margins. Unlike hypertrophic scars (which stay within the wound boundary and tend to flatten over time), keloids invade surrounding skin and rarely regress on their own .

The root of the problem is dysregulated fibroblast behavior in a setting of chronic inflammation. Research increasingly frames keloids as the product of prolonged inflammation in the reticular dermis: inflammatory signals keep stimulating fibroblasts long after they should have stood down, driving relentless collagen production and a disorganized, overgrown matrix . People with darker skin tones and a genetic predisposition are at significantly higher risk, and common trigger sites include the earlobes, chest, shoulders, and jawline.

This biology matters for understanding PDRN's role, because the keloid problem is not too little healing β€” it is too much, poorly regulated healing. Any ingredient considered for keloids has to be evaluated through that lens: does it help normalize and remodel collagen, or does it risk adding fuel to an already overactive process?

Where PDRN Fits β€” and Where It Doesn't

PDRN is best known as a regenerative, pro-healing molecule, which on the surface might seem counterintuitive for a condition defined by excess healing. But the more relevant features of PDRN for keloids are its anti-inflammatory action and its capacity to support organized tissue remodeling rather than chaotic collagen buildup.

Calming the Inflammation That Feeds Keloids

Since chronic inflammation is now understood as a central driver of keloid formation, PDRN's anti-inflammatory mechanism is the most relevant point of contact. Through adenosine A2A receptor activation, PDRN suppresses pro-inflammatory cytokines such as TNF-alpha and IL-6 . In theory, dampening the inflammatory signaling in and around a healing wound could reduce the prolonged fibroblast stimulation that drives keloid overgrowth. This is a mechanistic rationale, not a guarantee β€” but it aligns PDRN with the modern, inflammation-focused understanding of keloid biology .

Supporting Organized Remodeling

PDRN influences fibroblast activity and supports the production and organization of extracellular matrix during healing . In normal skin rejuvenation, this produces smoother, better-quality collagen . The hope in scar care is that PDRN can encourage more orderly remodeling of scar tissue β€” improving texture, pliability, and appearance β€” rather than the dense, disorganized collagen that characterizes keloids. PDRN's well-documented wound-healing and angiogenic effects also support healthier overall tissue quality during the critical post-injury window when scars are forming .

The Honest Limitations

Here is the crucial caveat: keloids are notoriously resistant to treatment, and there is no strong clinical evidence that topical PDRN alone resolves established keloids. Topical molecules struggle to penetrate the dense, thick collagen of a mature keloid. The settings where PDRN is most plausibly useful are:

  • As an injectable, administered by a clinician, where it can be delivered directly into or around scar tissue β€” a very different proposition from a home serum.
  • For scar prevention and early intervention, applied to healing wounds in keloid-prone individuals to support better-quality healing before a keloid establishes itself.
  • As part of combination therapy, supporting recovery between professional treatments.

Established keloids generally require dermatologist-led interventions: intralesional corticosteroid injections, silicone sheeting, cryotherapy, laser, pressure therapy, or surgical excision (always combined with adjuvant therapy, since excision alone often makes keloids recur worse). PDRN should be viewed as a possible complement to this toolkit, not a replacement.

A Sensible Approach to Using PDRN for Scars

For Keloid-Prone Wound Healing (Prevention)

If you scar badly and have a fresh wound, surgical site, or piercing, the prevention window is your best opportunity:

  1. Let the wound close first. Once the skin has re-epithelialized and your doctor confirms it is appropriate, begin gentle supportive care.
  2. Apply a fragrance-free PDRN serum to the healing area to support organized remodeling and provide anti-inflammatory support during the months when scar tissue matures.
  3. Add silicone. Silicone gel or sheeting is the best-evidenced over-the-counter scar prevention method; PDRN can be layered into a routine that includes it.
  4. Protect from the sun. UV exposure darkens and worsens scars β€” use sunscreen diligently on any healing scar.
  5. Be patient and consistent. Scar remodeling unfolds over 6 to 12 months; supportive care needs to be maintained across that whole window.

For Established Keloids

See a dermatologist. Pursue evidence-based treatments (intralesional steroids, laser, silicone, cryotherapy, or surgery with adjuvant therapy). Ask specifically whether injectable PDRN or PDRN-supported protocols are appropriate for your case β€” this is increasingly offered in aesthetic and dermatology clinics and is a more credible route than topical products for mature lesions. Use topical PDRN only as a supportive comfort measure if your clinician agrees.

What to Avoid

  • Don't traumatize keloid-prone skin unnecessarily. Elective procedures, aggressive exfoliation, and picking can all trigger or worsen keloids through repeated injury.
  • Don't expect a topical serum to flatten a mature keloid. Manage expectations honestly.
  • Don't skip professional care in favor of home treatment for an active, growing, or symptomatic keloid.

The Bottom Line

PDRN is mechanistically interesting for keloids because it targets the inflammation and fibroblast dysregulation now understood to drive them, and because it supports organized rather than chaotic healing. Its most realistic value is in prevention β€” supporting better-quality healing in keloid-prone skin β€” and as a clinician-administered or adjunctive option, rather than a topical cure for established lesions. Paired with silicone, sun protection, and dermatologist-led treatment, it can be a thoughtful part of a scar-care strategy. On its own, against a mature keloid, expectations should stay modest.

Frequently Asked Questions

Can PDRN flatten an existing keloid?

There is no strong evidence that topical PDRN flattens established keloids, which are dense and resistant to topical penetration. Established keloids need dermatologist-led treatments such as intralesional steroid injections, silicone, cryotherapy, laser, or surgery with adjuvant therapy. PDRN may have a more credible role as an injectable administered by a clinician or as supportive care, but as a home serum against a mature keloid, expectations should be modest.

Is PDRN useful for preventing keloids after surgery or piercing?

This is PDRN's most plausible scar application. In keloid-prone people, supporting better-organized healing during the months a scar matures may help reduce abnormal scarring. Once the wound has closed, a gentle PDRN serum β€” combined with silicone gel or sheeting and diligent sun protection β€” can be part of a prevention routine. Always confirm timing with your doctor, and never apply products to an open or infected wound.

Why would a healing ingredient help a scar caused by too much healing?

It seems paradoxical, but keloids are not simply excess healing β€” they are dysregulated healing driven by chronic inflammation . PDRN's relevant actions here are its anti-inflammatory effect (calming the signals that keep fibroblasts overactive) and its support for organized collagen remodeling rather than disordered buildup . The goal is more orderly, better-quality tissue, not more tissue.

Should I choose topical or injectable PDRN for keloids?

For mature keloids, injectable PDRN administered by a clinician is far more likely to reach the dense scar tissue than a topical product, and it can be combined with other in-clinic treatments. Topical PDRN is better suited to scar prevention on freshly healed skin and to general supportive comfort. Discuss which approach fits your situation with a dermatologist who treats keloids.

References

  1. [1]
    Ogawa R. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. International Journal of Molecular Sciences. 2017;18(3):606. doi:10.3390/ijms18030606
  2. [2]
    Squadrito F, Bitto A, Irrera N, Pizzino G, Pallio G, Minutoli L, Altavilla D. Pharmacological Activity and Clinical Use of PDRN. Current Pharmaceutical Design. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  3. [3]
    Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Current Pharmaceutical Design. 2020;26(17):2049-2056. doi:10.2174/1381612826666200113152555
  4. [4]
    Galeano M, Bitto A, Altavilla D, Minutoli L, Polito F, CalΓ² M, Lo Cascio P, Stagno d'Alcontres F, Squadrito F. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair and Regeneration. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
  5. [5]
    Bitto A, Polito F, Irrera N, D'Ascola A, Avenoso A, Nastasi G, Campo GM, Micali A, Squadrito F, Altavilla D. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor. Arthritis Research & Therapy. 2011;13(1):R28. doi:10.1186/ar3258
  6. [6]
    Kim TH, Kim JH, Lee SH, Park ES. Biostimulatory effects of polydeoxyribonucleotide for facial skin rejuvenation. Journal of Cosmetic Dermatology. 2019;18(6):1767-1773. doi:10.1111/jocd.12958
ShareTwitterLinkedIn

Recommended Products

Related Posts

Search

Search across products, blog posts, wiki articles, and more.